Lasola, Emie .

HRN: 11-97-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
AMPICILLIN 1GM (VIAL)
11/22/2023
11/23/2023
IV
2 G
IVTT
PROM X 6 Hrs, MSAF Thinly
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: